{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:42:55Z","timestamp":1776753775480,"version":"3.51.2"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijgc.2025.101667","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:10:08Z","timestamp":1738757408000},"page":"101667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-323X","authenticated-orcid":false,"given":"Olivia","family":"Le Saux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"McNeish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"D\u2019Incalci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ijgc.2025.101667_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ijgc.2025.101667_bib2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101667_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/his.13444","article-title":"Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy","volume":"72","author":"Park","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101667_bib5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101667_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0002-9378(69)90579-1","article-title":"Multiple malignancy in the upper genital canal","volume":"103","author":"Woodruff","year":"1969","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"25","key":"10.1016\/j.ijgc.2025.101667_bib10","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101667_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky061","article-title":"Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-Fim Protocol","volume":"2","author":"Samimi","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/PGP.0000000000000857","article-title":"Serous tubal intraepithelial carcinoma in a risk-reducing salpingo-oophorectomy specimen from a RAD51D mutation carrier: a case report","volume":"42","author":"Gregory-Davis","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ijgc.2025.101667_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2017.06.018","article-title":"Pathologic findings in breast, Fallopian tube, and ovary specimens in non-BRCA hereditary breast and\/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2","volume":"70","author":"Schoolmeester","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ijgc.2025.101667_bib15","article-title":"Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population","volume":"51","author":"Stewart","year":"2024","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101667_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the Fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.6322","article-title":"The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions","volume":"264","author":"Cheng","year":"2024","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.01.003","article-title":"The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal Fallopian tube epithelial cells","volume":"37","author":"Hu","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib23","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3802\/jgo.2022.33.e50","article-title":"TP53 variants in p53 signatures and the clonality of STICs in RRSO samples","volume":"33","author":"Akahane","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101667_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11620","article-title":"Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution","volume":"7","author":"Bartlett","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","article-title":"The Li\u2013Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube","volume":"220","author":"Xian","year":"2010","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-024-03406-1","article-title":"Human peritoneal fluid exerts ovulation- and nonovulation-sourced oncogenic activities on transforming fallopian tube epithelial cells","volume":"24","author":"Hsu","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"24","key":"10.1016\/j.ijgc.2025.101667_bib27","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-22-1620","article-title":"Spatial transcriptomic analysis of ovarian cancer precursors reveals reactivation of IGFBP2 during pathogenesis","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101667_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.14722","article-title":"Serous tubal intra-epithelial carcinoma: what do we really know at this point?","volume":"81","author":"Vang","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib30","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib31","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0b013e318264ae09","article-title":"Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the \u201csectioning and extensively examining the FIMbriated end\u201d (SEE-FIM) protocol?","volume":"32","author":"Mahe","year":"2013","journal-title":"Int J Gynecol Pathol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.101667_bib33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/PAS.0000000000001325","article-title":"Clinicopathologic and molecular features of paired cases of metachronous ovarian serous borderline tumor and subsequent serous carcinoma","volume":"43","author":"Chui","year":"2019","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"10.1016\/j.ijgc.2025.101667_bib34","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the Fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101667_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000001039","article-title":"Fallopian tube mucosal involvement in cervical gastric-type adenocarcinomas: report of a series with discussion of the distinction from synchronous in situ tubal lesions","volume":"42","author":"Rajendran","year":"2018","journal-title":"Am J Surg Pathol."},{"issue":"6B","key":"10.1016\/j.ijgc.2025.101667_bib36","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/j.1365-2559.2012.04194.x","article-title":"Fallopian tube metastases of non-gynaecological origin: a series of 20 cases emphasizing patterns of involvement including intra-epithelial spread","volume":"60","author":"Stewart","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ijgc.2025.101667_bib37","article-title":"Integrated Molecular Profiling Studies to Characterize the Cellular Origins of High-Grade Serous Ovarian Cancer","author":"Lawrenson","year":"2018","journal-title":"bioRxiv"},{"issue":"23","key":"10.1016\/j.ijgc.2025.101667_bib38","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1158\/1078-0432.CCR-17-0638","article-title":"Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses","volume":"23","author":"Hao","year":"2017","journal-title":"Clin Cancer Res."},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101667_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101667_bib41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/PGP.0000000000000604","article-title":"An alternate diagnostic algorithm for the diagnosis of intraepithelial Fallopian tube lesions","volume":"39","author":"Perrone","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/his.14902","article-title":"Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study","volume":"83","author":"Bogaerts","year":"2023","journal-title":"Histopathology."},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s44294-024-00016-0","article-title":"Deep learning detects premalignant lesions in the Fallopian tube","volume":"2","author":"Bogaerts","year":"2024","journal-title":"NPJ Womens Health"},{"key":"10.1016\/j.ijgc.2025.101667_bib45","article-title":"264 Diagnosis and management of an isolated serous tubal intraepithelial carcinoma: professionals\u2019 opinions","volume":"34","author":"Fisch","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","article-title":"Morphologic and molecular heterogeneity of high-grade serous carcinoma precursor lesions","volume":"48","author":"Chien","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2025.101667_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/his.12651","article-title":"Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum","volume":"67","author":"Singh","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","author":"Colombo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.ijgc.2025.101667_bib51","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101667_bib52","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ijc.33378","article-title":"Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels","volume":"148","author":"Crosbie","year":"2021","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ijgc.2025.101667_bib53","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jogc.2022.08.018","article-title":"Outcome and management of serous tubal intraepithelial carcinoma following opportunistic salpingectomy: systematic review and meta-analysis","volume":"44","author":"Ruel-Lalibert\u00e9","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"13","key":"10.1016\/j.ijgc.2025.101667_bib54","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/1471-0528.17919","article-title":"Diagnosis and management of isolated serous tubal intraepithelial carcinoma: a qualitative focus group study","volume":"131","author":"Negri","year":"2024","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00404-023-06919-8","article-title":"A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany","volume":"308","author":"van der Ven","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijgc.2025.101667_bib56","unstructured":"Guidelines detail. NCCN. Accessed July 14, 2024. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1453."},{"issue":"8","key":"10.1016\/j.ijgc.2025.101667_bib57","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","article-title":"Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis","volume":"37","author":"Bijron","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101667_bib58","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0000000000000639","article-title":"Outcomes of incidental Fallopian tube high-grade serous carcinoma and serous tubal intraepithelial carcinoma in women at low risk of hereditary breast and ovarian cancer","volume":"26","author":"Chay","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2019.03.003","article-title":"Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: prevalence of invasive and in-situ carcinoma, with follow-up","volume":"153","author":"Blok","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101667_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.951292","article-title":"Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: a systematic review of the literature","volume":"12","author":"Linz","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijgc.2025.101667_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2024.05.010","article-title":"Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1\/2 mutation carriers several years after risk-reducing salpingo-oophorectomy","volume":"187","author":"van den Berg","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.ijgc.2025.101667_bib62","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101667_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-019-0525-1","article-title":"Development of peritoneal Carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO)","volume":"12","author":"Stanciu","year":"2019","journal-title":"J Ovarian Res"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101667_bib65","article-title":"Clinical outcomes following identification of an incidental p53 signature in the fallopian tube","volume":"52","author":"MacARTHUR","year":"2024","journal-title":"Gynecol Oncol Rep"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101667_bib66","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib67","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cancers15041141","article-title":"Prophylactic radical fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective national pilot study","volume":"15","author":"Leblanc","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101667_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101667_bib69","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1007\/s00432-023-04578-5","article-title":"Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany","volume":"149","author":"Runnebaum","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101667_bib70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"725","key":"10.1016\/j.ijgc.2025.101667_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2556","article-title":"Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer","volume":"15","author":"Paracchini","year":"2023","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101667_bib72","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/2159-8290.CD-23-0313","article-title":"Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker","volume":"13","author":"Taylor","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijgc.2025.101667_bib73","article-title":"Profiling extracellular vesicles in circulation enables the early detection of ovarian cancer","author":"Jo","year":"2023","journal-title":"bioRxiv"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:40:21Z","timestamp":1772329221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1048891X25001926"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101667","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101667"}}